glp-1 generic drugs Mounjaro, Zepbound: May Soon Be Available GLP-1 Medications for Weight Loss

Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework

Yale Medicine experts explain who qualifies, who can prescribe, and what to expect.

Summary GLP-1 RAs alter gastrointestinal motility at all levels of the GI tract, with delayed gastric emptying being the most well characterized

Learn what retatrutide does and how it affects appetite, blood sugar and energy use

GLP-1 therapy is a proven tool for weight management and metabolic health, but side effects can interfere with consistency